(Total Views: 514)
Posted On: 02/04/2021 6:10:42 PM
Post# of 155783
FDA news from 02/04 on monoclonal
For therapeutics, particularly virus-targeting monoclonal antibodies, we are considering approaches to help expedite drug development in this key area, including discussing appropriate regulatory flexibilities.
https://content.govdelivery.com/accounts/USFD...ns/2bf92eb
For therapeutics, particularly virus-targeting monoclonal antibodies, we are considering approaches to help expedite drug development in this key area, including discussing appropriate regulatory flexibilities.
https://content.govdelivery.com/accounts/USFD...ns/2bf92eb
(2)
(0)
